舒尔佳品牌怎么样 申请店铺

我要投票 舒尔佳在减肥药行业中的票数:293 更新时间:2025-04-02
舒尔佳是哪个国家的品牌?「舒尔佳」是 鲁南制药集团股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人张贵民在1995期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力舒尔佳品牌出海!通过在本页面挂载舒尔佳品牌的产品链接和联系邮箱,可以提高舒尔佳产品曝光!跨境电商爆单神器,目前只要100元/年哦~

舒尔佳怎么样

鲁南制药集团股份有限公司是集中药、西药、生物制药的生产、科研、销售于一体的国家重点高新技术企业、国家创新型企业。设有国家手性制药工程技术研究中心、哺乳动物细胞高效表达国家工程实验室、中药制剂新技术国家重点实验室、国家级企业技术中心、博士后科研工作站、山东省生物制药行业技术中心、泰山学者岗位,被山东省政府评为“山东省纳税先进企业”。

集团成员企业包括鲁南厚普制药有限公司、鲁南贝特制药有限公司、山东新时代药业有限公司、鲁南新时代医药有限公司等八家子公司,现有员工8000余名,是一个充满进取活力的企业。

集团公司董事长、总经理赵志全从19万元净资产、2万元贷款起步,带领干部员工艰苦创业,铸就了“不怕困难、挑战困难、战胜困难”的企业精神,始终坚持“造福社会,创造美好生活”、“依靠职工办企业、办好企业为职工”的经营宗旨,十分注重企业文化建设,积极构建和谐企业,创造人与人和谐、人与企业和谐、人与自然和谐的人文环境。2006年,鲁南制药集团被评为“山东省劳动关系和谐企业”,获得“全国五一劳动奖状”。

科学技术是第一生产力,自主创新是第一竞争力,鲁南制药集团在建立自己的科研队伍的同时,还与华东理工大学联合组建了“鲁华生物技术研究所”,与山东大学组建了“超临界流体技术研究所”、“天然药物研究院”,先后与意大利、罗马尼亚等多个国际知名院所以及等80余所国内知名院所建立了长期合作关系。近年来公司已成功地完成了300多项研究课题,其中,国家科技支撑计划、国家863计划、国家重大新药创制专项、国家火炬计划、国家重点新产品计划等项目50多项,80个产品通过专家鉴定,30个产品达到国际先进水平,43个产品达到国内领先水平,80多个项目获得科学技术进步奖,其中国家科技进步二等奖5项,省科技进步奖20项。近年来已申报国际、国内发明专利272项(其中PCT专利17项),已获授权专利154项。申请注册商标960项,已获注册证881个,“鲁南”商标2006年被国家工商总局认定为驰名保护。

“保持化学制药的优势,大力发展中药,做强生物制药”的发展目标已经确定,规模宏大、门类齐全的鲁南制药集团正在成为国内领先、世界一流的医药综合科研生产基地。

Lunan Pharmaceutical Group Co., Ltd. is a national key high-tech enterprise and national innovative enterprise integrating the production, scientific research and sales of medicine, western medicine and biopharmaceutical. There are national research center of chiral pharmaceutical engineering technology, National Engineering Laboratory of mammalian cell high-efficiency expression, National Key Laboratory of new technology of traditional Chinese medicine preparation, national enterprise technology center, postdoctoral research workstation, Shandong biopharmaceutical industry technology center, and Taishan scholar posts, which are rated as "advanced tax payment enterprise of Shandong Province" by Shandong provincial government. The group's member enterprises include eight subsidiaries, including Lunan Houpu Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Shandong new era Pharmaceutical Co., Ltd., Lunan new era Pharmaceutical Co., Ltd., with more than 8000 employees. It is an enterprise full of enterprising vitality. Zhao Zhiquan, chairman and general manager of the group company, started with a net asset of 190000 yuan and a loan of 20000 yuan, led the cadres and employees to work hard to start their own businesses, and created the enterprise spirit of "not afraid of difficulties, challenging difficulties, and overcoming difficulties". He always adhered to the business tenet of "benefiting the society, creating a better life" and "depending on the employees to run the enterprise and run the enterprise for the employees", and paid great attention to the construction of enterprise culture To actively build a harmonious enterprise and create a harmonious human environment of human and human, human and enterprise, human and nature. In 2006, Lunan Pharmaceutical Group was awarded "Shandong Province labor relations harmonious enterprise" and "National May 1st Labor Award". Science and technology is the first productivity, and independent innovation is the first competitiveness. Lunan Pharmaceutical Group, while establishing its own scientific research team, has also jointly established "Luhua Biotechnology Research Institute" with East China University of science and technology, and "supercritical fluid technology research institute" and "natural medicine research institute" with Shandong University, successively with Italy, Romania and other internationally renowned The Institute has established long-term cooperative relations with more than 80 well-known domestic institutes. In recent years, the company has successfully completed more than 300 research projects, including more than 50 projects of national science and technology support plan, National 863 plan, national major new drug creation project, national torch plan, national key new product plan, etc., 80 products have passed expert appraisal, 30 products have reached the international advanced level, 43 products have reached the domestic leading level, and more than 80 projects have obtained science There are 5 second prizes of national science and technology progress awards and 20 provincial science and technology progress awards. In recent years, 272 international and domestic invention patents (including 17 PCT patents) have been applied and 154 authorized patents have been obtained. 960 registered trademarks have been applied for, and 881 have been registered. Lunan trademark was recognized as well-known protection by the State Administration of industry and Commerce in 2006. The development goal of "maintaining the advantages of chemical pharmacy, vigorously developing traditional Chinese medicine and strengthening biological pharmacy" has been determined. Lunan Pharmaceutical Group, with a large scale and complete categories, is becoming a leading pharmaceutical comprehensive research and production base in China and the world.

本文链接: https://brand.waitui.com/4b5271989.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

加力扩围发力显效,“两新”政策激发消费活力

4月1日,国家发展改革委消息显示,今年前两个月,“两新”政策进一步发力显效,带动设备工器具购置投资同比增长18%,社会消费品零售总额同比增长4%,继续发挥扩消费、稳投资、促转型、惠民生的重要作用。国家发展改革委指出,“两新”政策有效激发了消费活力。今年超长期特别国债支持消费品以旧换新资金规模增加至3000亿元,相较去年的资金规模翻了一番。首批810亿元资金于1月6日第一时间下达,延续2024年工作基础,扩围支持手机、平板、智能手表手环等数码产品购新。(证券时报)

2小时前

2024年中国为欧盟汽车进口最大来源国

4月1日,欧盟发布2024年欧盟汽车行业贸易数据,中国以127亿欧元进口额成为欧盟汽车进口最大来源国,欧方称,2019-2024五年间,欧盟自中国进口汽车增幅高达1591.3%;尽管如此,2024年欧盟对华汽车贸易保持顺差,对华出口高达145亿欧元。2024年,欧盟共出口汽车540万辆,进口汽车400万辆。与2019年相比,出口数量下降了13.2%,进口数量则减少了3.0%。(界面)

2小时前

业绩承诺仅完成6.7%,三鑫医疗高溢价投资面临追偿难

三年累计不低于4200万元的业绩承诺,实际完成280.42万元,完成率仅为6.7%,业绩承诺方暂时无法拿出充足的资金进行股份回购补偿。近日,三鑫医疗一则关于参股公司业绩承诺实现情况专项说明的公告引发众多投资者关注。有受访投行人士分析,高业绩承诺对应的一定是高估值,高估值就意味着高风险,这也提醒上市公司在投资时要紧紧围绕自身战略进行布局,真正做好风险控制。(上证报)

2小时前

全球风险资产震荡,市场静待关税靴子落地

美国即将于4月2日启动对等关税,引发市场连锁反应。美股三大指数上周集体下挫,亚太市场同步承压,避险资金则推动黄金现货价格触及3149.03美元/盎司的历史高位。随着政策实施时点临近,市场对美国经济政策框架的能见度逐步提升。部分机构表示,政策的可预测性上升,积极信号正在酝酿;也有机构对风险资产的表现感到担忧。尽管短期波动性骤增,但市场普遍认为,4月2日将为接下来几个月的金融市场走向定下基调。(中证网)

2小时前

中信建投:电解铝强调清洁能源代替,绿证市场有望加速成长

36氪获悉,中信建投证券研报显示,近期,工业和信息化部等十部门发布关于印发《铝产业高质量发展实施方案(2025—2027年)》。具体来看,《方案》鼓励企业参与光伏、风电等可再生能源和氢能、储能系统开发建设。推进氢氧化铝焙烧、铝用阳极焙烧环节实施清洁能源替代。在我国能耗双控转型的背景下,高耗能企业的清洁用能替代需求有望持续增长,有助于绿电、绿证市场的加速发展,有利于风光项目环境价值的兑现。

2小时前

本页详细列出关于泰尔维亭的品牌信息,含品牌所属公司介绍,泰尔维亭所处行业的品牌地位及优势。
咨询